What businesses in APAC should expect under a second Trump administration: Opportunities, challenges, and takeaways

What businesses in APAC should expect under a second Trump administration: Opportunities, challenges, and takeaways

As Americans head to the polls in an election that may well come down to the wire, now is our chance to take final stock of what the post-election future may hold for those impacted by China-U.S. relations, including the many businesses for which both markets are essential.
Sandpiper Appoints Liz Egginton to Lead Technology Practice

Sandpiper Appoints Liz Egginton to Lead Technology Practice

Based in Australia, Liz will lead the development and long-term growth of the firm’s Technology practice across Asia Pacific, integrating Sandpiper’s world-class offerings, including Content Strategy, Research and Insights, Government Affairs, Reputation Management, and International Media, to drive intentional and strategic communications outcomes for clients.
24 hours to go: What comes next for U.S.-China relations after the election?

24 hours to go: What comes next for U.S.-China relations after the election?

As Americans head to the polls in an election that may well come down to the wire, now is our chance to take final stock of what the post-election future may hold for those impacted by China-U.S. relations, including the many businesses for which both markets are essential.
Sandpiper Appoints Hermen Chow to its Financial and Professional Practices in Hong Kong

Sandpiper Appoints Hermen Chow to its Financial and Professional Practices in Hong Kong

Hermen will work alongside Sandpiper’s leadership and senior team to continue to grow the firm’s financial and professional services practices in Hong Kong and across Asia Pacific.
Top Trends to Shape Healthcare in 2024

Top Trends to Shape Healthcare in 2024

2024 is bringing a new set of changes, challenges, and opportunities to Asia Pacific’s healthcare sector. Shifting demographics, social changes, and new technologies such as cell and gene therapies, bio-inductive implants, and AI-assisted discovery are expected to reshape the industry.